Ersan, S. Et Al. 2017. Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury. CLINICAL NEPHROLOGY , vol.88, no.5 , 231-238.

Ersan, S., Çelik, A., Tanrisev, M., Kose, I., Çavdar, Z., Unlu, M., ... Kocak, A.(2017). Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury. CLINICAL NEPHROLOGY , vol.88, no.5, 231-238.

Ersan, Sibel Et Al. "Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury," CLINICAL NEPHROLOGY , vol.88, no.5, 231-238, 2017

Ersan, Sibel Et Al. "Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury." CLINICAL NEPHROLOGY , vol.88, no.5, pp.231-238, 2017

Ersan, S. Et Al. (2017) . "Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury." CLINICAL NEPHROLOGY , vol.88, no.5, pp.231-238.

@article{article, author={Sibel Ersan Et Al. }, title={Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury}, journal={CLINICAL NEPHROLOGY}, year=2017, pages={231-238} }